Moreover, as the PP2A phosphatase has been reported to modulate anticancer immunity (56), our finding of the CDC25B–PP2A interaction might impact tumor progression not only through regulating AMPK activity, but also through immune modulation. This evidence concerns the gene PTPA and neoplasm.